Keywords: 4 Amino 2 Oxabicyclo[3 1 0]hexane 4, 6 Dicarboxylic Acid, Alpha Amino 3 Hydroxy 5 Methyl 4 Isoxazolepropionic Acid, Amyloid Beta Protein, Bci 632, Bci 838, Beta Secretase 1, Excitatory Amino Acid Transporter 2, Gamma Secretase, Ionotropic Receptor, Kainic Acid Receptor, Ly566332, Metabotropic Receptor, Metabotropic Receptor Antagonist, Mitogen Activated Protein Kinase, Mitogen Activated Protein Kinase P38, N Methyl Dextro Aspartic Acid, N Methyl Dextro Aspartic Acid Receptor, Presenilin 1, Protein Tyrosine Phosphatase, Tau Protein, Transforming Growth Factor Beta1, Unclassified Drug, 4 Aminobutyric Acid Release, Alzheimer Disease, Amnesia, Animal Cell, Animal Experiment, Complex Formation, Controlled Study, Diffuse Lewy Body Disease, Dimerization, Disease Exacerbation, Down Regulation, Excitotoxicity, Gabaergic Transmission, Genetic Risk, Long Term Potentiation, Mouse, Nerve Cell Plasticity, Nervous System Development, Neuroprotection, Nonhuman, Priority Journal, Protein Aggregation, Protein Expression, Protein Folding, Protein Function, Protein Localization, Pyramidal Nerve Cell, Review, Signal Transduction, Synapse, Working Memory,
Affiliations: *** IBB - CNR ***
Department of Drug Sciences, University of Catania, Catania, Italy; Oasi Institute for Research on Mental Retardation and Brain Aging (IRCCS), Troina, Italy., Department of Physiology and Pharmacology, University of Rome Sapienza, Rome, Italy; Neuromed (IRCCS), Pozzilli, Italy., Department of Drug Sciences, University of Catania, Catania, Italy; Institute of Biostructure and Bioimaging, National Research Council, Catania, Italy. Electronic address: email@example.com.,
References: Not available.
Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease